SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-025475
Filing Date
2016-09-27
Accepted
2016-09-27 16:37:06
Documents
3
Period of Report
2016-09-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20160927.htm 8-K 30889
2 EX-99.1 xene-ex991_16.htm EX-99.1 10387
3 GRAPHIC gl5dqex0xdez000001.jpg GRAPHIC 1917
  Complete submission text file 0001564590-16-025475.txt   45274
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 161904782
SIC: 2834 Pharmaceutical Preparations